Fortunato Ciardiello
Cattedra di Oncologia Medica
Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica
Facoltà di Medicina e Chirurgia
Università degli Studi di Napoli Federico II
Italy
Name/email consistency: high
- Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. Ciardiello, F., Bianco, R., Caputo, R., Caputo, R., Damiano, V., Troiani, T., Melisi, D., De Vita, F., De Placido, S., Bianco, A.R., Tortora, G. Clin. Cancer Res. (2004)
- Antitumor effects of ZD6474, a small molecule vascular endothelial growth factor receptor tyrosine kinase inhibitor, with additional activity against epidermal growth factor receptor tyrosine kinase. Ciardiello, F., Caputo, R., Damiano, V., Caputo, R., Troiani, T., Vitagliano, D., Carlomagno, F., Veneziani, B.M., Fontanini, G., Bianco, A.R., Tortora, G. Clin. Cancer Res. (2003)
- ZD1839 (IRESSA), an EGFR-selective tyrosine kinase inhibitor, enhances taxane activity in bcl-2 overexpressing, multidrug-resistant MCF-7 ADR human breast cancer cells. Ciardiello, F., Caputo, R., Borriello, G., Del Bufalo, D., Biroccio, A., Zupi, G., Bianco, A.R., Tortora, G. Int. J. Cancer (2002)
- Anti-epidermal growth factor receptor drugs in cancer therapy. Ciardiello, F., Tortora, G. Expert. Opin. Investig. Drugs (2002)
- Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Fontanini, G., Cuccato, S., De Placido, S., Bianco, A.R., Tortora, G. Clin. Cancer Res. (2001)
- A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. Ciardiello, F., Tortora, G. Clin. Cancer Res. (2001)
- Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting type I protein kinase A. Ciardiello, F., Caputo, R., Pomatico, G., De Laurentiis, M., De Placido, S., Bianco, A.R., Tortora, G. Int. J. Cancer (2000)
- Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Ciardiello, F., Caputo, R., Bianco, R., Damiano, V., Pomatico, G., De Placido, S., Bianco, A.R., Tortora, G. Clin. Cancer Res. (2000)
- Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Ciardiello, F., Bianco, R., Damiano, V., Fontanini, G., Caputo, R., Pomatico, G., De Placido, S., Bianco, A.R., Mendelsohn, J., Tortora, G. Clin. Cancer Res. (2000)
- Epidermal growth factor receptor tyrosine kinase inhibitors as anticancer agents. Ciardiello, F. Drugs (2000)